Phase 4 Hemophilia A Clinical Trials
8 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–8 of 8 trials
Recruiting
Phase 4
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa
Hemophilia A
Swedish Orphan Biovitrum250 enrolled27 locationsNCT06940830
Recruiting
Phase 4
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Hemophilia A
Octapharma28 enrolled15 locationsNCT05936580
Recruiting
Phase 4
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With InhibitorHemophilia B With Inhibitor
American Thrombosis and Hemostasis Network55 enrolled21 locationsNCT04647227
Recruiting
Phase 4
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Severe Hemophilia A
Octapharma28 enrolled18 locationsNCT05935358
Recruiting
Phase 4
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Hemophilia A
Sanofi20 enrolled2 locationsNCT06145373
Recruiting
Phase 4
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
Hemophilia AFactor VIII
University of Texas Southwestern Medical Center28 enrolled1 locationNCT04690322
Recruiting
Phase 4
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China50 enrolled1 locationNCT05888870
Recruiting
Phase 4
Pharmacokinetic-guided Dosing of Emicizumab
AdultHemophilia A With InhibitorAdolescent+3 more
Kathelijn Fischer95 enrolled8 locationsNCT06320626